IRCT20200607047682N1已完成2 期
Clinical trial of the use of Annual SZ drug in the treatment of patients with Covid-19 disease in Emam Hosein hospital in Tehran.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 70 years（—）
- 性别
- All
入选标准
- •pationt infected with covid19
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Effects of Annual SZ drug on modulating immune responses and efficacy against COVID-19 infectioCovid-19.Covid 19 , Virus IdentifiedU07.1IRCT20201001048894N2Bandare-abbas University of Medical Sciences40
已完成
2 期
effect of Sovodak in patients with hepatitis C and HIV-1Condition 1: Hepatitis C and HIV. Condition 2: Human immunodeficiency virus.Acute hepatitis CHuman immunodeficiency virus [HIV] diseaseIRCT20180924041107N1Tabriz University of Medical Sciences22
进行中（未招募）
1 期
Ratifying dosage and duration for levo-bupivacaine, a local anaesthetic infusion by the caudal-epidural route in infants 3-6 months.EUCTR2015-000393-34-GBCentral Manchester University Hospitals NHS Foundation Trust10
招募中
1 期
Clinical Trial of Chinese Medicine in the Treatment of Cough Variant AsthmaCough variant asthmaITMCTR2000002990Oriental Hospital of Beijing University of Traditional Chinese Medicine
未知
Unknown
Clinical Pharmacology Study of Z-100 - Study on Immunological Parameter in Healthy AdultJPRN-jRCT2080221848Zeria Pharmaceutical Co., Ltd.120